Total planned funding: $205,804,039
Allocations
Countries/Regions
India | $205,804,039 |
Organizational Types
Unknown | $106,552,198 |
NGO | $46,812,560 |
Own Agency | $29,182,984 |
University | $9,240,217 |
Private Contractor | $4,098,272 |
Multi-lateral Agency | $3,116,808 |
Implementing Agency | $3,100,000 |
FBO | $2,500,000 |
Host Country Government Agency | $1,201,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $84,374,912 |
Prevention | $48,796,225 |
Care | $25,662,836 |
Management and Operations | $23,412,297 |
Testing | $10,048,185 |
Treatment | $9,081,792 |
Budget Codes
OHSS: Health Systems Strengthening | $48,880,243 |
HVSI: Strategic Information | $26,648,784 |
HVOP: Sexual Prevention: Other Sexual Prevention | $24,409,596 |
HVMS: Management and Operations | $23,412,297 |
HBHC: Care: Adult Care and Support | $15,943,311 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,824,319 |
HVCT: Testing: HIV Testing and Counseling | $10,048,185 |
HLAB: Laboratory Infrastructure | $8,845,885 |
HTXS: Treatment: Adult Treatment | $8,342,027 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,182,117 |
HKID: Care: Orphans and Vulnerable Children | $4,696,962 |
HVTB: Care: TB/HIV | $4,357,784 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,250,945 |
HMBL: Biomedical Prevention: Blood Safety | $2,129,248 |
PDTX: Treatment: Pediatric Treatment | $716,288 |
PDCS: Care: Pediatric Care and Support | $664,779 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$106,552,198
Countries/Regions
USG Aggregated Agencies:
$23,190,085
Countries/Regions
FHI 360:
$15,761,825
Countries/Regions
Voluntary Health Services:
$7,960,000
Countries/Regions